Transforming Appetite Management with Calocurb® CLINICAL
Ortho Molecular Products has teamed up with Calocurb® to introduce Calocurb® CLINICAL, an innovative solution aimed at managing appetite effectively. This partnership highlights a significant advancement in the nutrition industry by offering a product that focuses on real results for individuals seeking support in appetite control, exclusively under professional guidance.
Understanding Calocurb® CLINICAL
Calocurb® CLINICAL is a specialized, plant-based supplement formulated to aid individuals in managing their cravings and appetite. It features Amarasate®, a unique extract derived from hops, which has undergone extensive clinical validation. The formulation is the result of a significant investment in research and development, proving its efficacy through rigorous scientific studies.
The Science Behind Amarasate®
This powerful ingredient, Amarasate®, is delivered in a therapeutic dose of 250 mg. Clinical trials have demonstrated that it effectively reduces hunger levels by 30%, cravings by 40%, and overall calorie intake by 18% in just one hour after consumption. By targeting the small intestine, it activates crucial receptors that trigger the release of satiety hormones essential for regulating appetite and improving metabolic health.
Why Partnership Matters
This collaboration combines the strengths of two organizations dedicated to enhancing health outcomes through clinically supported products. Ortho Molecular Products, recognized for its commitment to quality and scientific integrity, aligns perfectly with Calocurb®’s dedication to developing effective nutritional solutions. Both companies are focused on providing healthcare practitioners with resources that equip them to better serve their patients.
A Statement from Leadership
Nate Freeman, the vice president of science and innovation at Ortho Molecular Products, emphasizes the importance of efficacy in product development. He states that Calocurb® CLINICAL is designed to create a positive impact on patients’ relationships with food, thereby promoting a healthier lifestyle. His belief in the power of evidence-based solutions is echoed by Sarah Kennedy, CEO of Calocurb®, who appreciates the alignment of their companies’ missions to improve patient health.
Availability and Future Outlook
Calocurb® CLINICAL will be exclusively available through licensed practitioners. This ensures that users will receive the necessary support and guidance to effectively utilize the product in their journey toward better appetite management. The product is set to become available for purchase in mid-2025, and is expected to make a substantial impact in the realm of dietary management.
About Ortho Molecular Products
For over three decades, Ortho Molecular Products has been at the forefront of nutraceutical manufacturing. The company is dedicated to fine-tuning its offerings to suit the unique needs of healthcare practitioners. Based in the Chicagoland area, their state-of-the-art, FDA-audited facility adheres to stringent quality standards, ensuring that every product meets high expectations for efficacy and safety.
About Calocurb® CLINICAL and Amarasate®
Calocurb® CLINICAL stands out as a cutting-edge supplement leveraging Amarasate®, a natural extract that fosters improved appetite regulation through hormonal response. Notably, it enhances the release of GLP-1, CCK, and PYY, all pivotal in managing appetite effectively and healthily.
Frequently Asked Questions
What is Calocurb® CLINICAL?
Calocurb® CLINICAL is a targeted appetite control supplement designed for professional use, featuring the patented ingredient Amarasate®.
How does Amarasate® work?
Amarasate® activates taste receptors in the small intestine, triggering the release of hormones that regulate appetite.
Who can purchase Calocurb® CLINICAL?
This product is available exclusively through licensed healthcare practitioners for better patient management.
What are the benefits of using Calocurb® CLINICAL?
It has shown to reduce hunger and cravings significantly, supporting individuals in achieving better dietary control.
When will Calocurb® CLINICAL be available for purchase?
Calocurb® CLINICAL is expected to launch in mid-2025, offering practitioners a new tool for appetite management.
